Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
van Schayck
C P
CP
University of Maastricht, Dept of General Practice, The Netherlands.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity
D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations